[Congenital toxoplasmosis. Evaluation of the benefit of prenatal therapy].
D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007933:Leucomycins / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D013411:Sulfadiazine / Q000627:therapeutic use*; D014123:Toxoplasmosis / Q000188:drug therapy*; D014125:Toxoplasmosis, Congenital / Q000517:prevention & control*
D007933:Leucomycins; D013411:Sulfadiazine
Toxoplasmose congénitale. Evaluation du bénéfice thérapeutique prénatal